InvestSMART

AVITA Medical, Inc. (ASX:AVH)

ALERT: Price-sensitive ASX Announcement for AVH
Current share price for AVH : $1.295 0.08 (6.58%)+
Release
1 May 2026 8:17AM
Price at Release
$1.215
Full Release
download
Summary
AVITA Medical, Inc., a leading company in therapeutic acute wound care, announced the appointment of Cary Vance as President and Chief Executive Officer. This decision followed his successful interim CEO role since October 2025 and a thorough search by the Board. Jan Stern Reed has been elected as Chair of the Board. Cary Vance's leadership is expected to drive the company through an exciting growth period, building on the momentum of their innovative product RECELL, which enhances wound healing. AVITA Medical continues to focus on increasing product adoption and supporting clinicians in delivering improved patient outcomes.
Key Points
  • Cary Vance appointed as President and CEO of AVITA Medical, Inc.
  • Jan Stern Reed elected as Chair of the AVITA Medical Board.
  • Cary Vance served as Interim CEO since October 2025.
  • AVITA Medical focuses on therapeutic acute wound care.
  • RECELL is a key product for treating thermal burn and trauma wounds.
  • Cary Vance has extensive experience in healthcare leadership.
  • AVITA Medical aims to support clinicians and improve patient outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.